Efter fornyet overvejelse af denne opfattelse konkluderede udvalget imidlertid, at lægemidlets beskedne virkning kan være en fordel for nogle patienter.
However, following a re-examination of this opinion, the Committee concluded that the medicine’ s modest effectiveness could also be of benefit to some patients.